TY - JOUR AU - Uplekar, M. AU - Weil, D. AU - Lonnroth, K. AU - Jaramillo, E. AU - Lienhardt, C. AU - Dias, H. M. PY - 2015 DA - 2015// TI - WHO’s new End TB Strategy JO - Lancet VL - 385 ID - Uplekar2015 ER - TY - BOOK PY - 2019 DA - 2019// TI - Global Tuberculosis Report 2019 PB - World Health Organization CY - Geneva ID - ref2 ER - TY - JOUR AU - Laurence, Y. V. AU - Griffiths, U. K. AU - Vassall, A. PY - 2015 DA - 2015// TI - Costs to health services and the patient of treating tuberculosis: a systematic literature review JO - PharmacoEconomics. VL - 33 ID - Laurence2015 ER - TY - STD TI - van den Hof S, Collins D, Hafidz F, et al. The socioeconomic impact of multidrug resistant tuberculosis on patients: results from Ethiopia, Indonesia and Kazakhstan. BMC Infect Dis. 2016;16:470. https://doi.org/10.1186/s12879-016-1802-x. ID - ref4 ER - TY - JOUR AU - Paterson, D. L. PY - 2004 DA - 2004// TI - “Collateral damage” from cephalosporin or quinolone antibiotic therapy JO - Clin Infect Dis VL - 38 ID - Paterson2004 ER - TY - JOUR AU - Meeren, O. AU - Hatherill, M. AU - Nduba, V. AU - Wilkinson, R. J. AU - Muyoyeta, M. AU - Brakel, E. PY - 2018 DA - 2018// TI - Phase 2b controlled trial of M72/AS01E vaccine to prevent tuberculosis JO - N Engl J Med VL - 379 ID - Meeren2018 ER - TY - JOUR AU - Nemes, E. AU - Geldenhuys, H. AU - Rozot, V. AU - Rutkowski, K. T. AU - Ratangee, F. AU - Bilek, N. PY - 2018 DA - 2018// TI - Prevention of M. tuberculosis infection with H4:IC31 vaccine or BCG revaccination JO - N Engl J Med VL - 379 ID - Nemes2018 ER - TY - JOUR AU - Knight, G. M. AU - Griffiths, U. K. AU - Sumner, T. AU - Laurence, Y. V. AU - Gheorghe, A. AU - Vassall, A. PY - 2014 DA - 2014// TI - Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries JO - Proc Natl Acad Sci VL - 111 ID - Knight2014 ER - TY - JOUR AU - Tseng, C. -. L. AU - Oxlade, O. AU - Menzies, D. AU - Aspler, A. AU - Schwartzman, K. PY - 2011 DA - 2011// TI - Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study JO - BMC Public Health VL - 11 ID - Tseng2011 ER - TY - BOOK PY - 2018 DA - 2018// TI - Global Tuberculosis Report 2018 PB - World Health Organization CY - Geneva ID - ref10 ER - TY - JOUR AU - Arinaminpathy, N. AU - Batra, D. AU - Khaparde, S. AU - Vualnam, T. AU - Maheshwari, N. AU - Sharma, L. PY - 2016 DA - 2016// TI - The number of privately treated tuberculosis cases in India: an estimation from drug sales data JO - Lancet Infect Dis VL - 16 ID - Arinaminpathy2016 ER - TY - JOUR AU - Fitzpatrick, C. AU - Hui, Z. AU - Lixia, W. AU - Renzhong, L. AU - Yunzhou, R. AU - Mingting, C. PY - 2015 DA - 2015// TI - Cost–effectiveness of a comprehensive programme for drug-resistant tuberculosis in China JO - Bull World Health Organ VL - 93 ID - Fitzpatrick2015 ER - TY - STD TI - R Core Team. R: A Language and Environment for Statistical Computing. Vienna; 2019. https://www.R-project.org/. Accessed 16 Apr 2020. UR - https://www.r-project.org/ ID - ref13 ER - TY - JOUR AU - Harris, R. C. AU - Sumner, T. AU - Knight, G. M. AU - Evans, T. AU - Cardenas, V. AU - Chen, C. PY - 2019 DA - 2019// TI - Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study JO - Lancet Glob Health VL - 7 ID - Harris2019 ER - TY - STD TI - Harris RC, Sumner T, Knight GM, Zhang H, White RG. Potential impact of tuberculosis vaccines in China, South Africa, and India. Science Translational Medicine; 2020;12(564):eaax4607. https://doi.org/10.1126/scitranslmed.aax4607. ID - ref15 ER - TY - JOUR AU - Sensi, P. PY - 1983 DA - 1983// TI - History of the development of rifampin JO - Clin Infect Dis VL - 5 ID - Sensi1983 ER - TY - JOUR AU - Murray, J. F. AU - Schraufnagel, D. E. AU - Hopewell, P. C. PY - 2015 DA - 2015// TI - Treatment of tuberculosis. a historical perspective JO - Ann Am Thorac Soc VL - 12 ID - Murray2015 ER - TY - JOUR AU - Fox, W. AU - Ellard, G. A. AU - Mitchison, D. A. PY - 1999 DA - 1999// TI - Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications JO - Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis VL - 3 ID - Fox1999 ER - TY - JOUR AU - Menzies, D. AU - Benedetti, A. AU - Paydar, A. AU - Martin, I. AU - Royce, S. AU - Pai, M. PY - 2009 DA - 2009// TI - Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis JO - Plos Med VL - 6 ID - Menzies2009 ER - TY - JOUR AU - Johnston, J. C. AU - Campbell, J. R. AU - Menzies, D. PY - 2017 DA - 2017// TI - Effect of intermittency on treatment outcomes in pulmonary tuberculosis: an updated systematic review and metaanalysis JO - Clin Infect Dis VL - 64 ID - Johnston2017 ER - TY - JOUR AU - Schaaf, H. S. AU - Collins, A. AU - Bekker, A. AU - Davies, P. D. O. PY - 2010 DA - 2010// TI - Tuberculosis at extremes of age JO - Respirology. VL - 15 ID - Schaaf2010 ER - TY - JOUR AU - Swaminathan, S. AU - Rekha, B. PY - 2010 DA - 2010// TI - Pediatric tuberculosis: global overview and challenges JO - Clin Infect Dis VL - 50 ID - Swaminathan2010 ER - TY - JOUR AU - Datta, M. AU - Swaminathan, S. PY - 2001 DA - 2001// TI - Global aspects of tuberculosis in children JO - Paediatr Respir Rev VL - 2 ID - Datta2001 ER - TY - JOUR AU - Rajagopalan, S. AU - Yoshikawa, T. T. PY - 2000 DA - 2000// TI - Tuberculosis in the elderly JO - Z Gerontol Geriatr VL - 33 ID - Rajagopalan2000 ER - TY - JOUR AU - Straetemans, M. AU - Glaziou, P. AU - Bierrenbach, A. L. AU - Sismanidis, C. AU - Werf, M. J. PY - 2011 DA - 2011// TI - Assessing tuberculosis case fatality ratio: a meta-analysis JO - Plos One VL - 6 ID - Straetemans2011 ER - TY - STD TI - Tiemersma EW, Werf MJ van der, Borgdorff MW, Williams BG, Nagelkerke NJD. Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review. Plos One. 2011;6:e17601. doi:10/ccsk8f. ID - ref26 ER - TY - JOUR AU - Cohen, T. AU - Sommers, B. AU - Murray, M. PY - 2003 DA - 2003// TI - The effect of drug resistance on the fitness of Mycobacterium tuberculosis JO - Lancet Infect Dis VL - 3 ID - Cohen2003 ER - TY - JOUR AU - Cohen, T. AU - Murray, M. PY - 2004 DA - 2004// TI - Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness JO - Nat Med VL - 10 ID - Cohen2004 ER - TY - JOUR AU - Knight, G. M. AU - Zimic, M. AU - Funk, S. AU - Gilman, R. H. AU - Friedland, J. S. AU - Grandjean, L. PY - 2018 DA - 2018// TI - The relative fitness of drug-resistant Mycobacterium tuberculosis: a modelling study of household transmission in Peru JO - J R Soc Interface VL - 15 ID - Knight2018 ER - TY - JOUR AU - Kendall, E. A. AU - Azman, A. S. AU - Cobelens, F. G. AU - Dowdy, D. W. PY - 2017 DA - 2017// TI - MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis JO - Plos One VL - 12 ID - Kendall2017 ER - TY - BOOK PY - 2018 DA - 2018// TI - WHO Tuberculosis Database ID - ref31 ER - TY - JOUR AU - Satyanarayana, S. AU - Nair, S. A. AU - Chadha, S. S. AU - Shivashankar, R. AU - Sharma, G. AU - Yadav, S. PY - 2011 DA - 2011// TI - From where are tuberculosis patients accessing treatment in India? Results from a cross-sectional community based survey of 30 districts JO - Plos One VL - 6 ID - Satyanarayana2011 ER - TY - JOUR AU - Yeole, R. D. AU - Khillare, K. AU - Chadha, V. K. AU - Lo, T. AU - Kumar, A. M. V. PY - 2015 DA - 2015// TI - Tuberculosis case notification by private practitioners in Pune, India: how well are we doing? JO - Public Health Action VL - 5 ID - Yeole2015 ER - TY - JOUR AU - Wang, L. AU - Zhang, H. AU - Ruan, Y. AU - Chin, D. P. AU - Xia, Y. AU - Cheng, S. PY - 2014 DA - 2014// TI - Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data JO - Lancet VL - 383 ID - Wang2014 ER - TY - BOOK PY - 2018 DA - 2018// TI - Report of the First National Anti-Tuberculosis Drug Resistance Survey India ID - ref35 ER - TY - BOOK PY - 2017 DA - 2017// TI - National Strategic Plan for Tuberculosis Elimination 2017–25 PB - Government of India CY - New Delhi ID - ref36 ER - TY - JOUR AU - Lin, H. -. H. AU - Wang, L. AU - Zhang, H. AU - Ruan, Y. AU - Chin, D. P. AU - Dye, C. PY - 2015 DA - 2015// TI - Tuberculosis control in China: use of modelling to develop targets and policies JO - Bull World Health Organ VL - 93 ID - Lin2015 ER - TY - STD TI - World Population Prospects 2019, Volume II: Demographic Profiles. :1238. ID - ref38 ER - TY - JOUR AU - Read, J. M. AU - Lessler, J. AU - Riley, S. AU - Wang, S. AU - Tan, L. J. AU - Kwok, K. O. PY - 2014 DA - 2014// TI - Social mixing patterns in rural and urban areas of southern China JO - Proc R Soc Lond B Biol Sci VL - 281 ID - Read2014 ER - TY - JOUR AU - Mossong, J. AU - Hens, N. AU - Jit, M. AU - Beutels, P. AU - Auranen, K. AU - Massari, M. PY - 2008 DA - 2008// TI - Social contacts and mixing patterns relevant to the spread of infectious diseases JO - Plos Med VL - 5 ID - Mossong2008 ER - TY - JOUR AU - Dye, C. AU - Williams, B. G. PY - 2008 DA - 2008// TI - Eliminating human tuberculosis in the twenty-first century JO - J R Soc Interface VL - 5 ID - Dye2008 ER - TY - JOUR AU - Abu-Raddad, L. J. AU - Sabatelli, L. AU - Achterberg, J. T. AU - Sugimoto, J. D. AU - Longini, I. M. AU - Dye, C. PY - 2009 DA - 2009// TI - Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics JO - Proc Natl Acad Sci U S A VL - 106 ID - Abu-Raddad2009 ER - TY - JOUR AU - Dye, C. AU - Garnett, G. P. AU - Sleeman, K. AU - Williams, B. G. PY - 1998 DA - 1998// TI - Prospects for worldwide tuberculosis control under the WHO DOTS strategy JO - Lancet VL - 352 ID - Dye1998 ER - TY - JOUR AU - Vynnycky, E. AU - Fine, P. E. PY - 1997 DA - 1997// TI - The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection JO - Epidemiol Infect VL - 119 ID - Vynnycky1997 ER - TY - JOUR AU - Gabriela, M. AU - Gomes, M. AU - Rodrigues, P. AU - Hilker, F. M. AU - Mantilla-Beniers, N. B. AU - Muehlen, M. AU - Cristina Paulo, A. PY - 2007 DA - 2007// TI - Implications of partial immunity on the prospects for tuberculosis control by post-exposure interventions JO - J Theor Biol VL - 248 UR - https://doi.org/10.1016/j.jtbi.2007.06.005 DO - 10.1016/j.jtbi.2007.06.005 ID - Gabriela2007 ER - TY - JOUR AU - Schulzer, M. AU - Fitzgerald, J. M. AU - Enarson, D. A. AU - Grzybowski, S. PY - 1992 DA - 1992// TI - An estimate of the future size of the tuberculosis problem in sub-Saharan Africa resulting from HIV infection JO - Tuber Lung Dis VL - 73 ID - Schulzer1992 ER - TY - JOUR AU - Yoshikawa, T. T. PY - 1992 DA - 1992// TI - Tuberculosis in aging adults JO - J Am Geriatr Soc VL - 40 ID - Yoshikawa1992 ER - TY - STD TI - High K, Marion C. Tuberculosis in Older Adults. In: Yoshikawa T, Norman D, editors. Infectious Disease in the Aging: A Clinical Handbook. 2nd edition. Totowa: Humana Press; 2009:97–110. ID - ref48 ER - TY - JOUR AU - Ferebee, S. H. PY - 1970 DA - 1970// TI - Controlled chemoprophylaxis trials in tuberculosis. A general review JO - Bibl Tuberc VL - 26 ID - Ferebee1970 ER - TY - JOUR AU - Marx, F. M. AU - Dunbar, R. AU - Enarson, D. A. AU - Williams, B. G. AU - Warren, R. M. AU - Spuy, V. D. PY - 2014 DA - 2014// TI - The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: a retrospective cohort study JO - Clin Infect Dis VL - 58 ID - Marx2014 ER - TY - JOUR AU - Perriëns, J. H. AU - St. Louis, M. E. AU - Mukadi, Y. B. AU - Brown, C. AU - Prignot, J. AU - Pouthier, F. PY - 1995 DA - 1995// TI - Pulmonary tuberculosis in HIV-infected patients in Zaire — a controlled trial of treatment for either 6 or 12 months JO - N Engl J Med VL - 332 ID - Perriëns1995 ER - TY - JOUR AU - Sharifi-Mood, B. AU - Metanat, M. AU - Alavi-Naini, R. AU - Kouhpayeh, H. -. R. AU - Salehi, M. AU - Naderi, M. PY - 2006 DA - 2006// TI - The comparison of six-month and four-month regimens of chemotherapy in the treatment of smear positive pulmonary tuberculosis JO - J Med Sci VL - 6 ID - Sharifi-Mood2006 ER - TY - JOUR AU - Felten, M. K. PY - 1989 DA - 1989// TI - Importance of rifampicin in combined daily/intermittent chemotherapy for tuberculosis JO - South Afr Med J Suid-Afr Tydskr Vir Geneeskd VL - 75 ID - Felten1989 ER - TY - JOUR AU - Combs, D. L. PY - 1990 DA - 1990// TI - USPHS tuberculosis short-course chemotherapy trial 21: effectiveness, toxicity, and acceptability: the report of final results JO - Ann Intern Med VL - 112 ID - Combs1990 ER - TY - JOUR AU - Holtz, T. H. AU - Sternberg, M. AU - Kammerer, S. AU - Laserson, K. F. AU - Riekstina, V. AU - Zarovska, E. PY - 2006 DA - 2006// TI - Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome JO - Ann Intern Med VL - 144 ID - Holtz2006 ER - TY - STD TI - World Health Organization. Guidelines for the treatment of drug-susceptible tuberculosis and patient care, 2017 update. World Health Organization; 2017. http://www.who.int/iris/handle/10665/255052. Accessed 18 Dec 2017. UR - http://www.who.int/iris/handle/10665/255052 ID - ref56 ER - TY - STD TI - World Health Organization. WHO consolidated guidelines on drug-resistant tuberculosis treatment. 2019. http://www.ncbi.nlm.nih.gov/books/NBK539517/. Accessed 7 Aug 2019. UR - http://www.ncbi.nlm.nih.gov/books/NBK539517/ ID - ref57 ER - TY - STD TI - Xu C, Pang Y, Li R, Ruan Y, Wang L, Chen M, et al. Clinical outcome of multidrug-resistant tuberculosis patients receiving standardized second-line treatment regimen in China. Journal of Infection. 2018;76:348–53. ID - ref58 ER - TY - BOOK PY - 2016 DA - 2016// TI - Global tuberculosis report 2016 ID - ref59 ER - TY - STD TI - Harris RC. Informing development strategies for new tuberculosis vaccines: mathematical modelling and novel epidemiological tools. Doctoral Thesis. London School of Hygiene & Tropical Medicine; 2018. http://researchonline.lshtm.ac.uk/4648987/. Accessed 2 Sept 2018. UR - http://researchonline.lshtm.ac.uk/4648987/ ID - ref60 ER - TY - BOOK AU - Funk, S. PY - 2017 DA - 2017// TI - socialmixr: R package for deriving social mixing matrices from survey data. R ID - Funk2017 ER - TY - JOUR AU - Sunnåker, M. AU - Busetto, A. G. AU - Numminen, E. AU - Corander, J. AU - Foll, M. AU - Dessimoz, C. PY - 2013 DA - 2013// TI - Approximate Bayesian Computation JO - Plos Comput Biol VL - 9 ID - Sunnåker2013 ER - TY - JOUR AU - Wegmann, D. AU - Leuenberger, C. AU - Excoffier, L. PY - 2009 DA - 2009// TI - Efficient Approximate Bayesian Computation Coupled With Markov Chain Monte Carlo Without Likelihood JO - Genetics VL - 182 ID - Wegmann2009 ER - TY - JOUR AU - Pandey, S. AU - Chadha, V. K. AU - Laxminarayan, R. AU - Arinaminpathy, N. PY - 2017 DA - 2017// TI - Estimating tuberculosis incidence from primary survey data: a mathematical modeling approach JO - Int J Tuberc Lung Dis VL - 21 ID - Pandey2017 ER - TY - JOUR AU - Shen, X. AU - DeRiemer, K. AU - Yuan, Z. AU - Shen, M. AU - Xia, Z. AU - Gui, X. PY - 2009 DA - 2009// TI - Deaths among tuberculosis cases in Shanghai, China: who is at risk? JO - BMC Infect Dis VL - 9 ID - Shen2009 ER - TY - JOUR AU - Wang, W. B. AU - Zhao, Q. AU - Yuan, Z. A. AU - Jiang, W. L. AU - Liu, M. L. AU - Xu, B. PY - 2013 DA - 2013// TI - Deaths of tuberculosis patients in urban China: a retrospective cohort study JO - Int J Tuberc Lung Dis VL - 17 ID - Wang2013 ER - TY - STD TI - Cheng J, Wang L, Zhang H, Xia Y. Diagnostic Value of Symptom Screening for Pulmonary Tuberculosis in China. PLoS ONE. 2015;10(5):e0127725. https://doi.org/10.1371/journal.pone.0127725. ID - ref67 ER - TY - STD TI - Glaziou P, Dodd PJ, Zignol M, Sismanidis K, Floyd K. Online Technical Appendix: WHO Global Tuberculosis Report 2018. https://www.who.int/tb/publications/global_report/gtbr2018_online_technical_appendix_global_disease_burden_estimation.pdf?ua=1. Accessed 12 Feb 2020. UR - https://www.who.int/tb/publications/global_report/gtbr2018_online_technical_appendix_global_disease_burden_estimation.pdf?ua=1 ID - ref68 ER - TY - JOUR AU - Zhao, Y. AU - Xu, S. AU - Wang, L. AU - Chin, D. P. AU - Wang, S. AU - Jiang, G. PY - 2012 DA - 2012// TI - National survey of drug-resistant tuberculosis in China JO - N Engl J Med VL - 366 ID - Zhao2012 ER - TY - BOOK PY - 2017 DA - 2017// TI - Global Tuberculosis Report 2017 PB - World Health Organizaton CY - Geneva ID - ref70 ER - TY - JOUR AU - Dodd, P. J. AU - Sismanidis, C. AU - Seddon, J. A. PY - 2016 DA - 2016// TI - Global burden of drug-resistant tuberculosis in children: a mathematical modelling study JO - Lancet Infect Dis VL - 16 ID - Dodd2016 ER - TY - JOUR AU - Tait, D. R. AU - Hatherill, M. AU - Meeren, O. AU - Ginsberg, A. M. AU - Brakel, E. AU - Salaun, B. PY - 2019 DA - 2019// TI - Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis JO - N Engl J Med VL - 381 ID - Tait2019 ER - TY - STD TI - World Health Organization. WHO preferred product characteristics for new tuberculosis vaccines. Technical documents. World Health Organization; 2018. http://apps.who.int/iris/handle/10665/273089. Accessed 16 Nov 2018. UR - http://apps.who.int/iris/handle/10665/273089 ID - ref73 ER - TY - STD TI - HPV Information Centre. Human Papillomavirus and Related Diseases Report. Institut Català d’Oncologia; 2017. http://www.hpvcentre.net/statistics/reports/ZAF.pdf. Accessed on 16 Apr 2020. UR - http://www.hpvcentre.net/statistics/reports/ZAF.pdf ID - ref74 ER - TY - STD TI - UNESCO Institute for Statistics. Education: gross enrolment ratio by level of education. UIS.Stat. http://data.uis.unesco.org/?queryid=142. Accessed 16 Apr 2020. UR - http://data.uis.unesco.org/?queryid=142 ID - ref75 ER - TY - BOOK AU - Harouna, D. M. PY - 2014 DA - 2014// TI - Roll out of the meningococcal a conjugate vaccine through mass vaccination campaigns in countries of the African meningitis belt ID - Harouna2014 ER - TY - JOUR AU - Wu, S. AU - Yang, P. AU - Li, H. AU - Ma, C. AU - Zhang, Y. AU - Wang, Q. PY - 2013 DA - 2013// TI - Influenza vaccination coverage rates among adults before and after the 2009 influenza pandemic and the reasons for non-vaccination in Beijing, China: a cross-sectional study JO - BMC Public Health VL - 13 ID - Wu2013 ER - TY - JOUR AU - Zheng, Y. AU - Yang, P. AU - Wu, S. AU - Ma, C. AU - Seale, H. AU - Macintyre, C. R. PY - 2013 DA - 2013// TI - A cross-sectional study of factors associated with uptake of vaccination against influenza among older residents in the postpandemic season in Beijing, China JO - BMJ Open VL - 3 ID - Zheng2013 ER - TY - JOUR AU - Das, B. R. AU - Kakoti, G. AU - Bahety, H. AU - Das, N. AU - Medhi, A. H. PY - 2014 DA - 2014// TI - Adult Japanese encephalitis mass vaccination campaign: a rapid convenience assessment JO - Int J Curr Res Acad Rev VL - 2 ID - Das2014 ER - TY - STD TI - Vassall A, Sweeney S, Kahn J, Gomez GB, Bollinger L, Marseille E, et al. Reference Case for Estimating the Costs of Global Health Services and Interventions. Global Health Cost Consortium; 2017. https://ghcosting.org/pages/standards/reference_case. Accessed 16 Apr 2020. UR - https://ghcosting.org/pages/standards/reference_case ID - ref80 ER - TY - JOUR AU - Mijiti, P. AU - Yuehua, L. AU - Feng, X. AU - Milligan, P. J. AU - Merle, C. AU - Gang, W. PY - 2016 DA - 2016// TI - Prevalence of pulmonary tuberculosis in western China in 2010–11: a population-based, cross-sectional survey JO - Lancet Glob Health VL - 4 ID - Mijiti2016 ER - TY - STD TI - Chatterjee S, Das P, Nigam A, et al. Variation in cost and performance of routine immunisation service delivery in India BMJ Global Health. 2018;3:e000794. ID - ref82 ER - TY - STD TI - Department of Health and Family Welfare, Ministry of Health and Family Welfare. Introduction of Measles-Rubella Vaccine National Operational Guidelines. New Delhi, India; 2017. https://main.mohfw.gov.in/sites/default/files/195431585071489665073.pdf. Accessed 1 May 2020. UR - https://main.mohfw.gov.in/sites/default/files/195431585071489665073.pdf ID - ref83 ER - TY - JOUR AU - Yu, W. AU - Lu, M. AU - Wang, H. AU - Rodewald, L. AU - Ji, S. AU - Ma, C. PY - 2018 DA - 2018// TI - Routine immunization services costs and financing in China, 2015 JO - Vaccine VL - 36 ID - Yu2018 ER - TY - JOUR AU - Yin, Z. AU - Beeler Asay, G. R. AU - Zhang, L. AU - Li, Y. AU - Zuo, S. AU - Hutin, Y. J. PY - 2012 DA - 2012// TI - An economic evaluation of the use of Japanese encephalitis vaccine in the expanded program of immunization of Guizhou province, China JO - Vaccine VL - 30 ID - Yin2012 ER - TY - JOUR AU - Hutton, D. W. AU - So, S. K. AU - Brandeau, M. L. PY - 2010 DA - 2010// TI - Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China JO - Hepatology VL - 51 ID - Hutton2010 ER - TY - JOUR AU - Floyd, K. AU - Arora, V. K. AU - Murthy, K. J. R. AU - Lonnroth, K. AU - Singla, N. AU - Akbar, Y. PY - 2006 DA - 2006// TI - Cost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from India JO - Bull World Health Organ VL - 84 ID - Floyd2006 ER - TY - JOUR AU - Pantoja, A. AU - Lönnroth, K. AU - Lal, S. S. AU - Chauhan, L. S. AU - Uplekar, M. AU - Padma, M. R. PY - 2009 DA - 2009// TI - Economic evaluation of public-private mix for tuberculosis care and control, India. Part II. Cost and cost-effectiveness JO - Int J Tuberc Lung Dis VL - 13 ID - Pantoja2009 ER - TY - JOUR AU - Rupert, S. AU - Vassall, A. AU - Raizada, N. AU - Khaparde, S. D. AU - Boehme, C. AU - Salhotra, V. S. PY - 2017 DA - 2017// TI - Bottom-up or top-down: unit cost estimation of tuberculosis diagnostic tests in India JO - Int J Tuberc Lung Dis VL - 21 ID - Rupert2017 ER - TY - STD TI - Department of Community Medicine & School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER) Chandigarh, Department for Health Research, Ministry of Health & Family Welfare, Health Technology Assessment in India, Public Health Foundation of India, Indian Institute of Techology, Madras, Tata Institute of Social Science. National Health System Cost Database for India. National Health System Cost Database for India. https://www.healtheconomics.pgisph.in/costing_web/index.php?action=Cost_data. Accessed 31 Mar 2020. UR - https://www.healtheconomics.pgisph.in/costing_web/index.php?action=Cost_data ID - ref90 ER - TY - BOOK AU - Stop, T. B. PY - 2020 DA - 2020// TI - Partnership. Medicines & Diagnostics Catalog - Global Drug Facility PB - Stop TB Partnership CY - Geneva ID - Stop2020 ER - TY - JOUR AU - Gotham, D. AU - Fortunak, J. AU - Pozniak, A. AU - Khoo, S. AU - Cooke, G. AU - Nytko, F. E. PY - 2017 DA - 2017// TI - Estimated generic prices for novel treatments for drug-resistant tuberculosis JO - J Antimicrob Chemother VL - 72 ID - Gotham2017 ER - TY - STD TI - World Health Organization. WHO-CHOICE. WHO. http://www.who.int/choice/en/. Accessed 18 Feb 2020. UR - http://www.who.int/choice/en/ ID - ref93 ER - TY - JOUR AU - Wang, G. AU - Wang, S. AU - Jiang, G. AU - Fu, Y. AU - Shang, Y. AU - Huang, H. PY - 2018 DA - 2018// TI - Incremental cost-effectiveness of the second Xpert MTB/RIF assay to detect Mycobacterium tuberculosis JO - J Thorac Dis VL - 10 ID - Wang2018 ER - TY - STD TI - Salomon JA, Haagsma JA, Davis A, Noordhout CM de, Polinder S, Havelaar AH, et al. Disability weights for the Global Burden of Disease 2013 study. Lancet Glob Health. 2015;3:e712–23. doi:10/gf3mm4. ID - ref95 ER - TY - STD TI - World Health Organization. WHO | Metrics: Disability-Adjusted Life Year (DALY). Health Statistics and Information Systems. 2014. http://www.who.int/healthinfo/global_burden_disease/metrics_daly/en/. Accessed 22 Aug 2018. UR - http://www.who.int/healthinfo/global_burden_disease/metrics_daly/en/ ID - ref96 ER - TY - BOOK AU - Claxton, K. P. AU - Revill, P. AU - Sculpher, M. AU - Wilkinson, T. AU - Cairns, J. AU - Briggs, A. PY - 2014 DA - 2014// TI - The gates reference case for economic evaluation PB - Bill Melinda Gates Found CY - Seattle ID - Claxton2014 ER - TY - STD TI - World Health Organization. Gear up to end TB: Introducing the end TB Strategy. Technical documents. World Health Organization; 2015. http://apps.who.int/iris/handle/10665/156394. Accessed 15 Nov 2018. UR - http://apps.who.int/iris/handle/10665/156394 ID - ref98 ER - TY - JOUR AU - Lönnroth, K. AU - Raviglione, M. PY - 2016 DA - 2016// TI - The WHO’s new End TB Strategy in the post-2015 era of the Sustainable Development Goals JO - Trans R Soc Trop Med Hyg VL - 110 ID - Lönnroth2016 ER - TY - BOOK PY - 2001 DA - 2001// TI - Macroeconomics and health : investing in health for economic development : executive summary PB - World Health Organization CY - Geneva ID - ref100 ER - TY - JOUR AU - Ochalek, J. AU - Lomas, J. AU - Claxton, K. PY - 2018 DA - 2018// TI - Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data JO - BMJ Glob Health VL - 3 ID - Ochalek2018 ER - TY - JOUR AU - Husereau, D. AU - Drummond, M. AU - Petrou, S. AU - Carswell, C. AU - Moher, D. AU - Greenberg, D. PY - 2013 DA - 2013// TI - Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement JO - BMC Med VL - 11 ID - Husereau2013 ER - TY - JOUR AU - Kendall, E. A. AU - Fofana, M. O. AU - Dowdy, D. W. PY - 2015 DA - 2015// TI - Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis JO - Lancet Respir Med VL - 3 ID - Kendall2015 ER - TY - JOUR AU - Sharma, A. AU - Hill, A. AU - Kurbatova, E. AU - Walt, M. AU - Kvasnovsky, C. AU - Tupasi, T. E. PY - 2017 DA - 2017// TI - Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study JO - Lancet Infect Dis VL - 17 ID - Sharma2017 ER - TY - JOUR AU - Zwerling, A. AU - Behr, M. A. AU - Verma, A. AU - Brewer, T. F. AU - Menzies, D. AU - Pai, M. PY - 2011 DA - 2011// TI - The BCG World Atlas: a database of global BCG vaccination policies and practices JO - Plos Med VL - 8 UR - https://doi.org/10.1371/journal.pmed.1001012 DO - 10.1371/journal.pmed.1001012 ID - Zwerling2011 ER - TY - JOUR AU - Mangtani, P. AU - Abubakar, I. AU - Ariti, C. AU - Beynon, R. AU - Pimpin, L. AU - Fine, P. E. M. PY - 2014 DA - 2014// TI - Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials JO - Clin Infect Dis VL - 58 ID - Mangtani2014 ER - TY - JOUR AU - Abubakar, I. AU - Pimpin, L. AU - Ariti, C. AU - Beynon, R. AU - Mangtani, P. AU - JAC, S. PY - 2013 DA - 2013// TI - Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis JO - Health Technol Assess Winch Engl VL - 17 ID - Abubakar2013 ER - TY - STD TI - Fifteen year follow up of trial of BCG vaccines in south India for tuberculosis prevention. Tuberculosis Research Centre (ICMR), Chennai. Indian J Med Res. 1999;110:56–69. ID - ref108 ER - TY - STD TI - Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group. Lancet Lond Engl. 1996;348:17–24. ID - ref109 ER -